Tranexamic Acid
Facelift Surgery
University of MinnesotaSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Facelift Surgery cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE University of Minnesota | Early Phase 1 | C |
Epinephrine University of Minnesota | Early Phase 1 | C |
Same molecule, other indications
Tranexamic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →